OncoCyte Return on Investment 2014-2025 | IMDX
Current and historical return on investment (ROI) values for OncoCyte (IMDX) over the last 10 years.
| OncoCyte ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-03-31 | $-0.06B | $0.01B | -12000.00% |
| 2024-12-31 | $-0.06B | $-0.01B | 2480.00% |
| 2024-09-30 | $-0.04B | 0.00% | |
| 2024-06-30 | $-0.04B | 0.00% | |
| 2024-03-31 | $-0.04B | 0.00% | |
| 2023-12-31 | $-0.03B | 0.00% | |
| 2023-09-30 | $-0.02B | 0.00% | |
| 2023-06-30 | $-0.02B | 0.00% | |
| 2023-03-31 | $-0.01B | 0.00% | |
| 2022-12-31 | $-0.02B | 0.00% | |
| 2022-09-30 | $-0.02B | 0.00% | |
| 2022-06-30 | $-0.03B | -136.00% | |
| 2022-03-31 | $-0.05B | -90.64% | |
| 2021-12-31 | $-0.05B | -69.45% | |
| 2021-09-30 | $-0.05B | $0.10B | -52.02% |
| 2021-06-30 | $-0.04B | $0.10B | -51.57% |
| 2021-03-31 | $-0.03B | $0.11B | -56.64% |
| 2020-12-31 | $-0.03B | $0.04B | -74.36% |
| 2020-09-30 | $-0.03B | $0.04B | -80.52% |
| 2020-06-30 | $-0.03B | $0.04B | -83.92% |
| 2020-03-31 | $-0.03B | $0.04B | -77.04% |
| 2019-12-31 | $-0.02B | $0.03B | -65.19% |
| 2019-09-30 | $-0.02B | $0.03B | -67.92% |
| 2019-06-30 | $-0.02B | $0.03B | -76.19% |
| 2019-03-31 | $-0.02B | $0.04B | -103.45% |
| 2018-12-31 | $-0.02B | $0.00B | -200.00% |
| 2018-09-30 | $-0.02B | $0.01B | -187.50% |
| 2018-06-30 | $-0.02B | $0.01B | -223.53% |
| 2018-03-31 | $-0.02B | $0.01B | -230.30% |
| 2017-12-31 | $-0.02B | $0.01B | -235.29% |
| 2017-09-30 | $-0.02B | $0.01B | -200.00% |
| 2017-06-30 | $-0.02B | $0.01B | -146.34% |
| 2017-03-31 | $-0.01B | $0.01B | -143.59% |
| 2016-12-31 | $-0.01B | $0.01B | -171.43% |
| 2016-09-30 | $-0.01B | $0.01B | -288.89% |
| 2016-06-30 | $-0.01B | $0.01B | -960.00% |
| 2016-03-31 | $-0.01B | 0.00% | |
| 2015-12-31 | $-0.01B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.121B | $0.002B |
| OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.550B | 26.36 |
| Elevance Health (ELV) | United States | $84.617B | 10.92 |
| CVS Health (CVS) | United States | $84.212B | 10.47 |
| Cencora (COR) | United States | $56.918B | 19.80 |
| Natera (NTRA) | United States | $23.467B | 0.00 |
| DiDi Global (DIDIY) | China | $22.356B | 23.75 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| Solventum (SOLV) | United States | $12.729B | 13.47 |
| CochLear (CHEOY) | Australia | $12.142B | 0.00 |
| ICON (ICLR) | Ireland | $11.829B | 11.00 |
| Revvity (RVTY) | United States | $11.196B | 19.27 |
| Viatris (VTRS) | United States | $10.411B | 3.58 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $8.892B | 23.61 |
| HealthEquity (HQY) | United States | $8.760B | 38.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.172B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.242B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.149B | 24.44 |
| BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
| Sotera Health (SHC) | United States | $3.233B | 18.37 |
| Alignment Healthcare (ALHC) | United States | $2.762B | 0.00 |
| Concentras Parent (CON) | United States | $2.658B | 15.36 |
| Organon (OGN) | United States | $2.535B | 2.69 |
| Surgery Partners (SGRY) | United States | $2.473B | 32.17 |
| PACS (PACS) | United States | $2.009B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.912B | 73.63 |
| Ardent Health (ARDT) | United States | $1.865B | 7.95 |
| Premier (PINC) | United States | $1.816B | 13.79 |
| Progyny (PGNY) | United States | $1.798B | 39.58 |
| GoodRx Holdings (GDRX) | United States | $1.643B | 32.86 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.136B | 8.64 |
| Establishment Labs Holdings (ESTA) | $1.093B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.56 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.873B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.633B | 9.58 |
| Embecta (EMBC) | United States | $0.571B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.525B | 0.00 |
| Enhabit (EHAB) | United States | $0.469B | 38.62 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.35 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| SBC Medicals (SBC) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.433B | 0.00 |
| Omada Health (OMDA) | $0.391B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.213B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| DocGo (DCGO) | United States | $0.162B | 26.50 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| So-Young (SY) | China | $0.119B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |